Y10S 530/825
Bacteria
Y10S530/825 (Bacteria) appears on 884 US grants and 319 published applications in this corpus.
Search patents in Y10S- Granted patents
- 884
- Published applications
- 319
- Assignees
- 409
- Inventors
- 1,321
- Latest grant
- 31 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 12 | 0 |
| 1978 | 5 | 0 |
| 1979 | 3 | 0 |
| 1980 | 8 | 0 |
| 1981 | 10 | 0 |
| 1982 | 13 | 0 |
| 1983 | 6 | 0 |
| 1984 | 23 | 0 |
| 1985 | 21 | 0 |
| 1986 | 13 | 0 |
| 1987 | 20 | 0 |
| 1988 | 16 | 0 |
| 1989 | 21 | 0 |
| 1990 | 27 | 0 |
| 1991 | 15 | 0 |
| 1992 | 23 | 0 |
| 1993 | 21 | 0 |
| 1994 | 15 | 0 |
| 1995 | 22 | 0 |
| 1996 | 16 | 0 |
| 1997 | 33 | 0 |
| 1998 | 51 | 0 |
| 1999 | 59 | 0 |
| 2000 | 39 | 0 |
| 2001 | 49 | 4 |
| 2002 | 33 | 27 |
| 2003 | 18 | 28 |
| 2004 | 26 | 25 |
| 2005 | 18 | 35 |
| 2006 | 29 | 22 |
| 2007 | 25 | 23 |
| 2008 | 19 | 24 |
| 2009 | 24 | 14 |
| 2010 | 29 | 20 |
| 2011 | 18 | 8 |
| 2012 | 14 | 19 |
| 2013 | 9 | 13 |
| 2014 | 10 | 2 |
| 2015 | 19 | 16 |
| 2016 | 13 | 9 |
| 2017 | 6 | 11 |
| 2018 | 12 | 6 |
| 2019 | 4 | 5 |
| 2020 | 5 | 4 |
| 2021 | 4 | 4 |
| 2022 | 0 | 0 |
| 2023 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis31 Oct 2023US 11,801,293 B2Children's Hospital & Research Center at Oakland
- Method of treating autoimmune inflammatory crohn's disease28 Mar 2023US 11,612,636 B2Actinobac Biomed, Inc.
- Immunogenic compositions for the prevention and treatment of meningococcal disease14 Sep 2021US 11,116,829 B2Wyeth Holdings Corporation
- Treatment and diagnosis of inflammatory disorders and HIV4 May 2021US 10,993,989 B2Actinobac Biomed, Inc.
- Mutated immunoglobulin-binding protein16 Feb 2021US 10,918,971 B2Cytiva BioProcess R&D AB
- Treatment and diagnosis of inflammatory disorders and hiv4 Nov 2021US 2021/0338772 A1Actinobac Biomed, Inc.
- GNA1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis7 Oct 2021US 2021/0308247 A1Children's Hospital & Research Center at Oakland
- Mutated Immunoglobulin-Binding Polypeptides3 Jun 2021US 2021/0162319 A1Cytiva BioProcess R&D AB
- Flagellin related polypeptides and uses thereof29 Apr 2021US 2021/0121520 A1The Cleveland Clinic Foundation
- Treatment and diagnosis of inflammatory disorders and hiv1 Oct 2020US 2020/0306339 A1Actinobac Biomed, Inc.
Most cited
By later US patents
- Purification and activity assurance of precipitated heterologous proteins229US 4,511,503 AGenentech, Inc. · 1985
- Purification and activity assurance of precipitated heterologous proteins212US 4,511,502 AGenentech, Inc. · 1985
- Immunogenic polysaccharide-protein conjugates208US 4,356,170 ACanadian Patents and Development Limited · 1982
- Purification and activity assurance of precipitated heterologous proteins206US 4,512,922 AGenentech, Inc. · 1985
- Primate hematopoietic growth factors IL-3 and pharmaceutical compositions195US 4,959,455 AGenetics Institute, Inc. · 1990